FDA Strategy 2025: Policy, Pressures and the Path to Medtech Clearance | Part I | leanRAQA Today | S5:E6

22/10/2025 23 min Temporada 5 Episodio 6

Listen "FDA Strategy 2025: Policy, Pressures and the Path to Medtech Clearance | Part I | leanRAQA Today | S5:E6"

Episode Synopsis

The FDA state of the union in 2025 - deregulation, QMSR, and a toilet paper shortage?Listen in as Michelle Lott and Tianna Benson tackle the wild world of FDA policy shifts and what they mean for medical device manufacturers. From the administration’s sweeping deregulation mandates to the long-awaited transition from QSR to QMSR, they connect the dots between chaos, comedy, and compliance.You’ll hear:How the FDA’s current freeze on new regulations is reshaping device approval pathwaysWhat the shift from QSR to QMSR really means for your quality systemWhy De Novo submissions are both a blessing and a black box right nowAnd yes… how a literal shortage of office supplies at FDA HQ ties into all of thisWhether you’re a regulatory pro, a QA lead, or just someone who enjoys watching bureaucracy unfold in real time, this episode will help you decode what’s happening at the FDA — and how to stay one step ahead.Subscribe to the leanRAQA Today podcast for even more bold, insightful conversations that make medtech regulation make sense.Watch the video on YouTube: https://youtu.be/5vQjrwYforYVisit us at https://leanraqa.com/ for even more regulatory goodness and to learn more about our services.